A comparative evaluation of ultrasound molecular imaging, perfusion imaging, and volume measurements in evaluating response to therapy in patient-derived xenografts

Technology in Cancer Research and Treatment

Volumn 12, Issue 4, 2013, Pages 311-321

  Streeter, J E ^a   Herrera Loeza, S G ^b   Neel, N F ^b,c   Yeh, J J ^b,c   Dayton, P A ^a,b  

^a USA and North Carolina State University   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

3 D; Microbubbles; Molecular imaging; Perfusion imaging; Response to therapy; Ultrasound

Indexed keywords

1,2 DISTEAROYL SN GLYCERO 3 PHOSPHOCHOLINE; 1,2 DISTEAROYL SN GLYCERO 3 PHOSPHOETHANOLMINE N METHOXY POLYETHYLENE GLYCOL 2000; ALISERTIB; CONTRAST MEDIUM; CYCLIC RGD PEPTIDE; MOLECULAR MARKER; PHOSPHORYLCHOLINE; UNCLASSIFIED DRUG; AZEPINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; MEASUREMENT; MOLECULAR IMAGING; MOUSE; NONHUMAN; SCINTIGRAPHY; TREATMENT RESPONSE; TUMOR VOLUME; XENOGRAFT; ANIMAL; COMPARATIVE STUDY; DRUG SCREENING; EVALUATION STUDY; HUMAN; PROCEDURES; THREE DIMENSIONAL IMAGING; ULTRASOUND;

ANIMALS; AZEPINES; CONTRAST MEDIA; HUMANS; IMAGING, THREE-DIMENSIONAL; MICE; MOLECULAR IMAGING; PERFUSION IMAGING; PYRIMIDINES; TUMOR BURDEN; ULTRASONICS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84879238436     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.7785/tcrt.2012.500321     Document Type: Article

References (51)

1. Fu, J., Bian, M., Jiang, Q., Zhang, C. Roles of aurora kinases in mitosis and tumorigenesis. Mol Cancer Res 5(1), 1-10 (2007). DOI: 10.1158/1541-7786.MCR-06-0208
2. Glover, D. M., Leibowitz, M. H., McLean, D. A., Parry, H. Mutations in aurora prevent centrosome separation leading to the formation of monopolar spindles. Cell 81(1), 95-105 (1995). DOI: 10.1016/0092-8674(95)90374-7
3. Hirota, T., Kunitoku, N., Sasayama, T., Marumoto, T., Zhang, D., Nitta, M., Hatakeyama, K., Saya, H. Aurora-A and an interacting activator, the lim protein ajuba, are required for mitotic commitment in human cells. Cell 114(5), 585-598 (2003). DOI:10.1016/S0092-8674(03)00642-1
4. Li, D., Zhu, J., Firozi, P. F., Abbruzzese, J. L., Evans, D. B., Cleary, K., Friess, H., Sen, S. Overexpression of oncogenic stk15/btak/aurora a kinase in human pancreatic cancer. Clin Cancer Res 9(3), 991-997 (2003).
5. Tatsuka, M., Katayama, H., Ota, T., Tanaka, T., Odashima, S., Suzuki, F., Terada, Y. Multinuclearity and increased ploidy caused by overexpression of the aurora-and ipl1-like midbody-associated protein mitotic kinase in human cancer cells. Cancer Res 58(21), 4811-4816 (1998).
6. Zhou, H., Kuang, J., Zhong, L., Kuo, W. L., Gray, J. W., Sahin, A., Brinkley, B. R., Sen, S. Tumour amplified kinase stk15/btak induces centrosome amplification, aneuploidy and transformation. Nat Genet 20(2), 189-193 (1998). DOI: 10.1038/2496
7. Katayama, H., Ota, T., Jisaki, F., Ueda, Y., Tanaka, T., Odashima, S., Suzuki, F., Terada, Y., Tatsuka, M. Mitotic kinase expression and colorectal cancer progression. J Natl Cancer Inst 91(13), 1160-1162 (1999). DOI: 10.1093/jnci/91.13.1160
8. Gautschi, O., Heighway, J., Mack, P. C., Purnell, P. R., Lara, P. N., Gandara, D. R. Aurora kinases as anticancer drug targets. Clin Cancer Res 14(6), 1639-1648 (2008). DOI: 10.1158/1078-0432.CCR-07-2179
9. Kovar, H. Aurka inhibitors: right in time. Pediatr Blood Cancer 55(1), 3-4 (2010). DOI: 10.1002/pbc.22548
10. Michalski, M. H., Chen, X. Molecular imaging in cancer treatment. Eur J Nucl Med Mol Imaging 38(2), 358-377 (2011). DOI: 10.1007/s00259-010-1569-z
11. Van den Abbeele, A. D., Gatsonis, C., de Vries, D. J., Melenevsky, Y., Szot-Barnes, A., Yap, J. T., Godwin, A. K., Rink, L., Huang, M., Blevins, M., Sicks, J., Eisenberg, B., Siegel, B. A. ACRIN 6665/RTOG 0132 Phase II trial of neoadjuvant imatinib mesylate for operable malignant gastrointestinal stromal tumor: monitoring with 18F-FDG PET and correlation with genotype and GLUT4 expression. J Nucl Med 53(4), 567-574 (2012). DOI: 10.2967/jnumed.111.094425
12. Prior, J. O., Montemurro, M., Orcurto, M. V., Michielin, O., Luthi, F., Benhattar, J., Guillou, L., Elsig, V., Stupp, R., Delaloye, A. B., Leyvraz, S. Early prediction of response to sunitinib after imatinib failure by 18F-fluorodeoxyglucose positron emission tomography in patients with gastrointestinal stromal tumor. J Clin Oncol 27(3), 439-445 (2009). DOI: 10.1200/JCO.2008.17.2742
13. Lanza, G. M., Wickline, S. Targeted ultrasonic contrast agents for molecular imaging and therapy. Curr Probl Cardiol 28(12), 625-653 (2003). DOI: 10.1016/j.cpcardiol.2003.11.001
14. Lindner, J. R., Dayton, P. A., Coggins, M. P., Ley, K. F., Song, J., Ferrara, K. W., Kaul, S. Noninvasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles. Circulation 102(5), 531-538 (2000). DOI: 10.1161/ 01.CIR.102.5.531
15. Lindner, J. R. Molecular imaging of cardiovascular disease with contrast-enhanced ultrasonography. Nat Rev Cardiol 6(7), 475-481 (2009). DOI: 10.1038/nrcardio.2009.77
16. Dayton, P. A., Ferrara, K. W. Targeted imaging using ultrasound. J Magn Reson Imaging 16(4), 362-377 (2002). DOI: 10.1002/jmri.10173
17. Lindner, J. R., Coggins, M. P., Kaul, S., Klibanov, A. L., Brandenburger, G. H., Ley, K. F. Microbubble persistence in the microcirculation during ischemia/reperfusion and inflammation is caused by integrin-and complement-mediated adherence to activated leukocytes. Circulation 101(6), 668-675 (2000). DOI: 10.1161/ 01.CIR.101.6.668
18. Villanueva, F. S., Lu, E., Bowry, S., Kilic, S., Tom, E. M., Wang, J., Gretton, J., Pacella, J. J., Wagner, W. R. Myocardial ischemic memory imaging with molecular echocardiography. Circulation 115(3), 345-352 (2007). DOI: 10.1161/CIRCULATIONAHA.106.633917
19. Villanueva, F. S., Jankowski, R. J., Klibanov, S., Pina, M. L., Alber, S. M., Watkins, S. C., Brandenburger, G. H., Wagner, W. R. Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. Circulation 98(1), 1-5 (1998). DOI: 10.1161/ 01.CIR.98.1.1
20. Weinberg, R. The Biology of Cancer. Garland Science, Taylor and Francis Group, LLC, New York (2007). DOI: 10.1002/bmb.20199
21. Kim, D., Chung, J. Akt: versatile mediator of cell survival and beyond. J Biochem Mol Biol 35(1), 106-115 (2002). DOI: 10.5483/BMBRep.2002.35.1.106
22. Lin, Y. H., Lee, C. C., Chan, W. L., Chang, W. H., Wu, Y. C., Chang, J. G. 16-hydroxycleroda-3,13-dien-15,16-olide deregulates pi3k and aurora b activities that involve in cancer cell apoptosis. Toxicology 285(1-2), 72-80 (2011). DOI: 10.1016/j.tox.2011.04.004
23. Leong-Poi, H., Christiansen, J. P., Klibanov, A. L., Kaul, S., Lindner, J. R. Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to alpha(v)-integrins. Circulation 107(3), 455-460 (2003). DOI: 10.1161/01.CIR.0000044916.05919.8B
24. Schumann, P. A., Christiansen, J. P., Quigley, R. M., McCreery, T. P., Sweitzer, R. H., Unger, E. C., Lindner, J. R., Matsunaga, T. O. Targeted-microbubble binding selectively to gpiib iiia receptors of platelet thrombi. Invest Radiol 37(11), 587-593 (2002). DOI: 10.1097/01.RLI.0000031077.17751.B2
25. Willmann, J. K., Kimura, R. H., Deshpande, N., Lutz, A. M., Cochran, J. R., Gambhir, S. S. Targeted contrast-enhanced ultrasound imaging of tumor angiogenesis with contrast microbubbles conjugated to integrin-binding knottin peptides. J Nucl Med 51(3), 433-440 (2010). DOI: 10.2967/jnumed.109.068007
26. Willmann, J. K., Paulmurugan, R., Chen, K., Gheysens, O., Rodriguez-Porcel, M., Lutz, A. M., Chen, I. Y., Chen, X., Gambhir, S. S. Us imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. Radiology 246(2), 508-518 (2008). DOI: 10.1148/radiol.2462070536
27. Weller, G. E. R., Lu, E., Csikari, M. M., Klibanov, A. L., Fischer, D., Wagner, W. R., Villanueva, F. S. Ultrasound imaging of acute cardiac transplant rejection with microbubbles targeted to intercellular adhesion molecule-1. Circulation 108(2), 218-224 (2003). DOI: 10.1161/01.CIR.0000080287.74762.60
28. Streeter, J. E., Gessner, R. C., Tsuruta, J., Feingold, S., Dayton, P. A. Assessment of molecular imaging of angiogenesis with three-dimensional ultrasonography. Mol Imaging 10(6), 460-468 (2011). DOI: 10.2310/7290.2011.00015
29. Streeter, J. E., Gessner, R. C., Miles, I., Dayton, P. A. Improving sensitivity in ultrasound molecular imaging by tailoring contrast agent size distribution: in vivo studies. Mol Imaging 9(2), 87-95 (2010). DOI: 10.2310/7290.2010.00005
30. Pochon, S., Tardy, I., Bussat, P., Bettinger, T., Brochot, J., von Wronski, M., Passantino, L., Schneider, M. Br55: a lipopeptide-based vegfr2-targeted ultrasound contrast agent for molecular imaging of angiogenesis. Invest Radiol 45(2), 89-95 (2010). DOI: 10.1097/RLI.0b013e3181c5927c
31. Palmowski, M., Huppert, J., Ladewig, G., Hauff, P., Reinhardt, M., Mueller, M. M., Woenne, E. C., Jenne, J. W., Maurer, M., Kauffmann, G. W., Semmler, W., Kiessling, F. Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effects. Mol Cancer Ther 7(1), 101-109 (2008). DOI: 10.1158/1535-7163.MCT-07-0409
32. Wei, K., Jayaweera, A. R., Firoozan, S., Linka, A., Skyba, D. M., Kaul, S. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 97(5), 473-483 (1998). DOI: 10.1161/ 01.CIR.97.5.473
33. Pollard, R. E., Sadlowski, A. R., Bloch, S. H., Murray, L., Wisner, E. R., Griffey, S., Ferrara, K. W. Contrast-assisted destruction-replenishment ultrasound for the assessment of tumor microvasculature in a rat model. Technol Cancer Res Treat 1(6), 459-470 (2002).
34. Pollard, R. E., Dayton, P. A., Watson, K. D., Hu, X., Guracar, I. M., Ferrara, K. W. Motion corrected cadence cps ultrasound for quantifying response to vasoactive drugs in a rat kidney model. Urology 74(3), 675-681 (2009). DOI: 10.1016/j.urology.2009.01.086
35. Stieger, S. M., Bloch, S. H., Foreman, O., Wisner, E. R., Ferrara, K. W., Dayton, P. A. Ultrasound assessment of angiogenesis in a matrigel model in rats, Ultrasound Med Biol 32(5), 673-681 (2006). DOI: 10.1016/j.ultrasmedbio.2005.12.008
36. Du, J., Li, F. H., Fang, H., Xia, J.-G., Zhu, C.-X. Correlation of real-time gray scale contrast-enhanced ultrasonography with microvessel density and vascular endothelial growth factor expression for assessment of angiogenesis in breast lesions. J Ultrasound Med 27(6), 821-831 (2008).
37. Foote, R. L., Weidner, N., Harris, J., Hammond, E., Lewis, J. E., Vuong, T., Ang, K. K., Fu, K. K. Evaluation of tumor angiogenesis measured with microvessel density (mvd) as a prognostic indicator in nasopharyngeal carcinoma: results of rtog 9505. Int J Radiat Oncol Biol Phys 61(3), 745-753 (2005). DOI: 10.1016/j.ijrobp.2004.07.694
38. El-Assal, O. N., Yamanoi, A., Soda, Y., Yamaguchi, M., Igarashi, M., Yamamoto, A., Nabika, T., Nagasue, N. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver. Hepatology 27(6), 1554-1562 (1998). DOI: 10.1002/hep.510270613
39. Sirsi, S. R., Flexman, M. L., Vlachos, F., Huang, J., Hernandez, S. L., Kim, H. K., Johung, T. B., Gander, J. W., Reichstein, A. R., Lampl, B. S., Wang, A., Hielscher, A. H., Kandel, J. J., Yamashiro, D. J., Borden, M. A. Contrast ultrasound imaging for identification of early responder tumor models to anti-angiogenic therapy. Ultrasound Med Biol 38(6), 1019-1029 (2012). DOI: 10.1016/j.ultrasmedbio.2012.01.014
40. Feingold, S., Gessner, R. C., Guracar, I. M., Dayton, P. A. Quantitative volumetric perfusion mapping of the microvasculature using contrast ultrasound. Invest Radiol 45(10), 669-674 (2010). DOI: 10.1097/RLI.0b013e3181ef0a78
41. Hoyt, K., Sorace, A., Saini, R. Quantitative mapping of tumor vascularity using volumetric contrast-enhanced ultrasound. Invest Radiol 47(3), 167-174 (2012). DOI: 10.1097/RLI.0b013e318234e6bc
42. Rubio-Viqueira, B., Jimeno, A., Cusatis, G., Zhang, X., Iacobuzio-Donahue, C., Karikari, C., Shi, S., Danenberg, K., Danenberg, P. V., Kuramochi, H., Tanaka, K., Singh, S., Salimi-Moosavi, H., Bouraoud, N., Amador, M. L., Altiok, S., Kulesza, P., Yeo, C., Messersmith, W., Eshleman, J., Hruban, R. H., Maitra, A., Hidalgo, M. An in vivo platform for translational drug development in pancreatic cancer. Clin Cancer Res 12(15), 4652-4661 (2006). DOI: 10.1158/1078-0432.CCR-06-0113
43. Decaudin, D. Primary human tumor xenografted models ('tumorgrafts') for good management of patients with cancer. Anticancer Drugs 22(9), 827-841 (2011). DOI: 10.1097/CAD.0b013e3283475f70
44. Ruoslahti E. Integrins as signaling molecules and targets for tumor therapy. Kidney Int 51(5), 1413-1417 (1997). DOI: 10.1038/ki.1997.193
45. Sirsi, S., Feshitan, J. A., Kwan, J., Homma, S., Borden, M. A. Effect of microbubble size on fundamental mode high frequency ultrasound imaging in mice. Ultrasound Med Biol 36(6), 935-948 (2010). DOI: 10.1016/j.ultrasmedbio.2010.03.015
46. Feshitan, J. A., Chen, C. C., Kwan, J. J., Borden, M. A. Microbubble size isolation by differential centrifugation. J Colloid Interface Sci 329(2), 316-324 (2009). DOI: 10.1016/j.jcis.2008.09.066
47. Stieger, S. M., Dayton, P. A., Borden, M. A., Caskey, C. F., Griffey, S. M., Wisner, E. R., Ferrara, K. W. Imaging of angiogenesis using cadence contrast pulse sequencing and targeted contrast agents. Contrast Media Mol Imaging 3(1), 9-18 (2008). DOI: 10.1002/cmmi.224
48. Guibal, A., Taillade, L., Mule, S., Comperat, E., Badachi, Y., Golmard, J. L., Guillou-Buffello, D., Rixe, O., Bridal, S. L., Lucidarme, O. Noninvasive contrast-enhanced US quantitative assessment of tumor microcirculation in a murine model: effect of discontinuing anti-VEGF therapy. Radiology 254(2), 420-429 (2010). DOI: 10.1148/radiol.09090728
49. Zhou, J., Cao, L., Liu, J., Zheng, W., Liu, M., Luo, R., Han, F., Li, A. Quantitative assessment of tumor blood flow in mice after treatment with different doses of an antiangiogenic agent with contrast-enhanced destruction-replenishment US. Radiology 259(2), 406-413 (2011). DOI: 10.1148/radiol.10101339
50. Ayers, G. D., McKinley, E. T., Zhao, P., Fritz, J. M., Metry, R. E., Deal, B. C., Adlerz, K. M., Coffey, R. J., Manning, H. C. Volume of preclinical xenograft tumors is more accurately assessed by ultrasound imaging than manual caliper measurements. J Ultrasound Med 29(6), 891-901 (2010).
51. Euhus, D. M., Hudd, C., LaRegina, M. C., Johnson, F. E. Tumor measurement in the nude mouse. J Surg Oncol 31(4), 229-234 (1986). DOI: 10.1002/jso.2930310402